BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17133163)

  • 1. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
    Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
    Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cholera in breast-fed children by antibodies in breast milk.
    Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Hossain KM; Huq MI; Holmgren J
    N Engl J Med; 1983 Jun; 308(23):1389-92. PubMed ID: 6843632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion.
    Yoshiyama Y; Brown WR
    Immunology; 1987 Aug; 61(4):543-7. PubMed ID: 3443455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
    Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
    Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.
    Clemens JD; Sack DA; Chakraborty J; Rao MR; Ahmed F; Harris JR; van Loon F; Khan MR; Yunis M; Huda S
    Vaccine; 1990 Oct; 8(5):469-72. PubMed ID: 2251873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-feeding children in the household as a risk factor for cholera in rural Bangladesh: an hypothesis.
    Riley LW; Waterman SH; Faruque AS; Huq MI
    Trop Geogr Med; 1987 Jan; 39(1):9-14. PubMed ID: 3603697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
    Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Huda S; Huq MI; Holmgren J
    Pediatr Infect Dis J; 1989 Feb; 8(2):105-9. PubMed ID: 2704600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against mortality due to Vibrio cholerae infection in infant rabbits caused by immunization of mothers with cholera protective antigen.
    Sciortino CV
    J Diarrhoeal Dis Res; 1996 Mar; 14(1):16-26. PubMed ID: 8708328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study.
    Rothenbacher D; Weyermann M; Beermann C; Brenner H
    Clin Exp Allergy; 2005 Aug; 35(8):1014-21. PubMed ID: 16120082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroepidemiological survey of El Tor cholera in an endemic region of Algeria].
    Bendib A; Nora M; Mahrouf H; Saib M; el Abassi K; Dodin A
    Bull Soc Pathol Exot; 1994; 87(3):143-7. PubMed ID: 7827512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
    Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
    Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human milk: Defense against infection.
    Hanson LA; Söderström T
    Prog Clin Biol Res; 1981; 61():147-59. PubMed ID: 6798576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
    Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding stimulates total and cow's milk-specific salivary IgA in infants.
    Piirainen L; Pesola J; Pesola I; Komulainen J; Vaarala O
    Pediatr Allergy Immunol; 2009 May; 20(3):295-8. PubMed ID: 19438984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
    Jertborn M; Svennerholm AM; Holmgren J
    J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-family transmission of Vibrio cholerae during a cholera epidemic in rural south-southern Nigeria.
    Udonwa NE; Udoh SM; Ikpeme B; Andy I
    Trop Doct; 2008 Jul; 38(3):179-80. PubMed ID: 18628554
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
    Majumdar AS; Dutta P; Dutta D; Ghose AC
    Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.